Biotherapeutics Tenant Doubles Space in Silicon Valley

Biotherapeutics Tenant Doubles Space in Silicon Valley

Rani Therapeutics, LLC, a clinical-stage biotherapeutics company focused on oral delivery of biologics and drugs, has expanded its footprint in Silicon Valley with a new lease for 33,340 square feet of manufacturing, R&D and administrative space in Fremont. The company’s subsidiary has signed the lease at Bayside Commons technology park owned by BKM Capital Partners.

The strategic location along the I-880 Corridor offers convenience to Rani’s existing facilities in North San Jose and Milpitas. Cushman & Wakefield represented Rani in this expansion deal.

According to Alex Lagemann from Cushman & Wakefield,”This market expansion showcases Silicon Valley as a key global hub for biotech/life sciences companies.” With this move,Rani is nearly doubling its space from approximately 34,000 square feet.

About the Publisher:
Steve Griffin is based in sunny Palm Harbor, Florida. He’s an accountant by profession and the owner of GRIFFIN Tax and REVVED Up Accounting. In addition, Steve founded Madison Avenue Technology. With a strong passion for commercial real estate, he’s also dedicated to keeping you up to date with the latest industry news.

Share the Post:

Related Posts